Figure 1 | British Journal of Cancer

Figure 1

From: A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

Figure 1

Efficacy of BelCaP in a patient with rectal cancer. Response in a patient with metastatic rectal carcinoma treated with BelCaP showing an adrenal metastasis at baseline, (A) (encircled in red) measuring 7.7 cm, and after six cycles, (B) measuring 3.6 cm. The patient also had retroperitoneal lymph node metastases and with this, showed a confirmed PR. (See online version for color information).

Back to article page